ES504323A0 - Un procedimiento para la preparacion de un compuesto - Google Patents
Un procedimiento para la preparacion de un compuestoInfo
- Publication number
- ES504323A0 ES504323A0 ES504323A ES504323A ES504323A0 ES 504323 A0 ES504323 A0 ES 504323A0 ES 504323 A ES504323 A ES 504323A ES 504323 A ES504323 A ES 504323A ES 504323 A0 ES504323 A0 ES 504323A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/173,207 US4309545A (en) | 1980-07-28 | 1980-07-28 | Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8301926A1 ES8301926A1 (es) | 1982-12-16 |
ES504323A0 true ES504323A0 (es) | 1982-12-16 |
Family
ID=22630983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES504323A Granted ES504323A0 (es) | 1980-07-28 | 1981-07-27 | Un procedimiento para la preparacion de un compuesto |
Country Status (29)
Country | Link |
---|---|
US (1) | US4309545A (de) |
EP (1) | EP0045171B1 (de) |
JP (1) | JPS57112372A (de) |
KR (1) | KR850000273B1 (de) |
AR (1) | AR230988A1 (de) |
AT (1) | ATE11775T1 (de) |
AU (1) | AU525944B2 (de) |
CA (1) | CA1178274A (de) |
CS (1) | CS228515B2 (de) |
DD (1) | DD202012A5 (de) |
DE (1) | DE3168891D1 (de) |
DK (1) | DK334581A (de) |
EG (1) | EG15535A (de) |
ES (1) | ES504323A0 (de) |
FI (1) | FI812338L (de) |
GR (1) | GR75283B (de) |
GT (1) | GT198170557A (de) |
HU (1) | HU185133B (de) |
IE (1) | IE51426B1 (de) |
IL (1) | IL63423A0 (de) |
IN (1) | IN158867B (de) |
NO (2) | NO812557L (de) |
NZ (1) | NZ197856A (de) |
PH (1) | PH17281A (de) |
PL (1) | PL133928B1 (de) |
PT (1) | PT73440B (de) |
SU (1) | SU1217254A3 (de) |
YU (1) | YU185181A (de) |
ZA (1) | ZA815128B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642373A (en) * | 1982-03-16 | 1987-02-10 | Pfizer Inc. | Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents |
US4473704A (en) * | 1982-03-16 | 1984-09-25 | Pfizer Inc. | Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents |
US4920221A (en) * | 1982-03-16 | 1990-04-24 | Pfizer Inc. | Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines |
US5605906A (en) * | 1995-03-24 | 1997-02-25 | Merck Frosst Canada, Inc. | Cannabinoid receptor agonists |
EE03523B1 (et) * | 1996-01-31 | 2001-10-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine |
JP4141501B2 (ja) * | 1996-03-26 | 2008-08-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規の6位置換フェナントリジン |
US6127378A (en) * | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
US5776482A (en) * | 1996-03-29 | 1998-07-07 | University Of Iowa Research Foundation | Tetrahydroquinoline analogues for use in glaucoma treatment |
JP2001510827A (ja) * | 1997-07-25 | 2001-08-07 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 置換6−フェニルフェナントリジン |
DK1000034T3 (da) * | 1997-07-25 | 2003-01-27 | Altana Pharma Ag | Substituerede 6-alkylphenanthridiner |
JP2002539246A (ja) | 1999-03-22 | 2002-11-19 | イミュジェン ファーマシューティカルズ インコーポレイティッド | 免疫疾患の治療 |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
US20060084021A1 (en) * | 2004-09-10 | 2006-04-20 | Kubicek Chris A | Wick holder |
WO2002026728A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
WO2002026224A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
WO2003080043A1 (en) * | 2002-03-18 | 2003-10-02 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
ZA200610032B (en) * | 2004-05-25 | 2008-11-26 | Othera Holding Inc | Oculoselective drugs and prodrugs |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839441A (en) * | 1969-10-27 | 1974-10-01 | Hoffmann La Roche | Intermediates for partially hydrogenated phenanthridines |
US3878219A (en) * | 1973-07-13 | 1975-04-15 | Abbott Lab | 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines |
US3928598A (en) * | 1973-11-05 | 1975-12-23 | Lilly Co Eli | Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug |
US4087545A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs |
HU180916B (hu) | 1976-05-17 | 1983-05-30 | Pfizer | Eljárás benzo[c]kinolin-származékok előállítására |
SE7704749L (sv) * | 1976-05-17 | 1977-12-05 | Pfizer | Kinoliner och forfarande och mellanprodukter for framstellning derav |
US4152450A (en) * | 1978-02-17 | 1979-05-01 | Eli Lilly And Company | 9-Amino-dibenzopyrans |
-
1980
- 1980-07-28 US US06/173,207 patent/US4309545A/en not_active Expired - Lifetime
-
1981
- 1981-07-03 IN IN429/DEL/81A patent/IN158867B/en unknown
- 1981-07-21 EP EP81303339A patent/EP0045171B1/de not_active Expired
- 1981-07-21 GT GT198170557A patent/GT198170557A/es unknown
- 1981-07-21 AT AT81303339T patent/ATE11775T1/de not_active IP Right Cessation
- 1981-07-21 DE DE8181303339T patent/DE3168891D1/de not_active Expired
- 1981-07-22 HU HU812141A patent/HU185133B/hu not_active IP Right Cessation
- 1981-07-22 SU SU813317052A patent/SU1217254A3/ru active
- 1981-07-23 CS CS815647A patent/CS228515B2/cs unknown
- 1981-07-23 PL PL1981232331A patent/PL133928B1/pl unknown
- 1981-07-24 IE IE1686/81A patent/IE51426B1/en unknown
- 1981-07-24 CA CA000382558A patent/CA1178274A/en not_active Expired
- 1981-07-24 AR AR286204A patent/AR230988A1/es active
- 1981-07-24 GR GR65624A patent/GR75283B/el unknown
- 1981-07-24 DD DD81232067A patent/DD202012A5/de unknown
- 1981-07-27 IL IL63423A patent/IL63423A0/xx unknown
- 1981-07-27 DK DK334581A patent/DK334581A/da not_active Application Discontinuation
- 1981-07-27 JP JP56117571A patent/JPS57112372A/ja active Pending
- 1981-07-27 ES ES504323A patent/ES504323A0/es active Granted
- 1981-07-27 YU YU01851/81A patent/YU185181A/xx unknown
- 1981-07-27 AU AU73434/81A patent/AU525944B2/en not_active Ceased
- 1981-07-27 FI FI812338A patent/FI812338L/fi not_active Application Discontinuation
- 1981-07-27 KR KR1019810002717A patent/KR850000273B1/ko active
- 1981-07-27 NO NO812557A patent/NO812557L/no unknown
- 1981-07-27 EG EG431/81A patent/EG15535A/xx active
- 1981-07-27 ZA ZA815128A patent/ZA815128B/xx unknown
- 1981-07-27 NZ NZ197856A patent/NZ197856A/en unknown
- 1981-07-27 PH PH25968A patent/PH17281A/en unknown
- 1981-07-28 PT PT73440A patent/PT73440B/pt not_active IP Right Cessation
-
1985
- 1985-11-08 NO NO854454A patent/NO854454L/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES499079A0 (es) | Un procedimiento para la preparacion de un compuesto | |
ES505517A0 (es) | Un procedimiento para la preparacion de un derivado de n- arilbenzamida | |
ES499077A0 (es) | Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos | |
ES504103A0 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
ES502906A0 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina | |
ES487381A0 (es) | Un procedimiento para la preparacion de un compuesto de guanidinotiazol | |
ES505950A0 (es) | Un procedimiento para la preparacion de un derivado de tia- zol | |
ES505678A0 (es) | Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol | |
ES506141A0 (es) | Un procedimiento para la preparacion de piridin- y pira- cin-derivados | |
ES502792A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
ES502994A0 (es) | Un procedimiento para la preparacion de derivados de pirazo-lopiridacina | |
ES499559A0 (es) | Un procedimiento para la preparacion de derivados de pirrol | |
ES498922A0 (es) | Un procedimiento para la preparacion de compuestos de polie-ter antibioticos | |
ES504323A0 (es) | Un procedimiento para la preparacion de un compuesto | |
ES534218A0 (es) | Un procedimiento para la preparacion de compuestos de bencimidazol | |
ES499242A0 (es) | Un procedimiento para la preparacion de un compuesto de ce- falosporina | |
ES504764A0 (es) | Un procedimiento para la preparacion de un derivado 2-tiope-nem | |
ES504376A0 (es) | Un procedimiento para la preparacion de un derivado de fene-tilamina | |
ES492230A0 (es) | Un procedimiento para la preparacion de nuevos derivados de carbostirilo | |
ES505019A0 (es) | Un procedimiento para la preparacion de compuestos | |
ES503565A0 (es) | Un procedimiento para la preparacion de tilactona o un esterderivado de la misma | |
ES501232A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
ES500911A0 (es) | Un procedimiento para la preparacion de derivados de ergoli-na | |
ES499572A0 (es) | Un procedimiento para la preparacion de nuevas guanilamidi- nas | |
ES498145A0 (es) | Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas |